Related Experiment Video

Updated: Sep 19, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Cost effectiveness of cholesterol-lowering therapy in The Netherlands. Simvastatin versus cholestyramine

L L Martens1, F F Rutten, D W Erkelens

  • 1Department of Health Economics, Limburg State University, Maastricht, The Netherlands.

The American Journal of Medicine
|October 16, 1989
PubMed

Insights

Simvastatin is a more cost-effective treatment for high cholesterol than cholestyramine, offering significant savings per year of life saved. Early initiation of simvastatin therapy enhances its value in preventing coronary heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Pharmacoeconomics

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Elevated serum cholesterol levels are a primary risk factor for CHD.
  • Statins and bile acid sequestrants are established therapies for hypercholesterolemia.

Purpose of the Study:

  • To compare the cost-effectiveness of simvastatin versus cholestyramine for CHD prevention.
  • To evaluate the economic impact of lipid-lowering therapies based on patient age and cholesterol levels.

Main Methods:

  • Utilized a CHD incidence model based on Framingham Heart Study data.
  • Employed multivariate logistic regression functions to estimate outcomes.
  • Calculated cost-effectiveness ratios in Dutch guilders per year of life saved.

Main Results:

  • For men with initial cholesterol of 310 mg/dl, cholestyramine cost-effectiveness ranged from 220,000 to 510,000 guilders/year of life saved.
  • Simvastatin demonstrated superior cost-effectiveness, ranging from 50,000 to 110,000 guilders/year of life saved for the same group.
  • Similar cost-effectiveness patterns were observed in women, though generally less favorable.

Conclusions:

  • Simvastatin is substantially more cost-effective than cholestyramine for CHD prevention.
  • Simvastatin's cost-effectiveness is comparable to other accepted medical practices, particularly when initiated early.
  • Simvastatin is recommended as a first-choice drug for elevated cholesterol, pending further long-term safety data.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...